Annual Conference


Live Virtual Program was held Thursday, March 18, 2021 – Saturday, March 20, 2021

Continuing Education

Conference attendees will have the opportunity to view conference sessions on-demand in the Digitell platform through May 20, 2021. Recorded sessions will be available in the NCCN Continuing Education Portal,, in May.

Designed to meet the needs and improve the competence and performance of the interprofessional oncology care team, including physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other relevant health care professionals who manage the care of patients with cancer, the NCCN 2021 Virtual Annual Conference offered more than 35 educational sessions covering a range of topics:

  • Updates to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
  • New and emerging therapies, controversies in treatment, and best practices in the delivery of oncology care
  • Issues surrounding HPV vaccination
  • Racial disparities in guideline-adherent cancer care
  • Effects of the pandemic on cancer care
  • Best practices for incorporating patient-reported outcomes into oncology care 
This activity is supported by educational grants from: AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Deciphera Pharmaceuticals; Eisai; Exact Sciences; Gilead Sciences; GRAIL, Inc.; Ipsen Biopharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.; Lilly; Olympus Corporation of the Americas; Novartis; Pfizer; Taiho Oncology; and TeSera Therapeutics. This activity is supported by independent medical education grants from: Astellas; Bristol Myers Squibb; Boehringer Ingelheim Pharmaceuticals, Inc.; Illumina, Inc.; and Karyopharm® Therapeutics. This activity is supported by educational funding provided by Amgen. This project has been made possible in part by a grant from Varian Medical Systems /Global Medical Education Grant Program.

As of 1/11/21


General Poster Session

Conference attendees can continue to access all abstracts and posters and listen to recorded poster overviews presented by authors in the Digitell platform through May 20, 2021.

More than 90 posters have been accepted to participate in the NCCN Virtual Poster Exhibition Hall throughout the following categories.  

  • Clinical Oncology (all phases)
  • Epidemiology/Risks/Prevention
  • Best Practices in Implementation and Use of Clinical Practice Guidelines
  • Quality Improvement
  • Outcomes and Health Services Research
  • Bioinformatics/Information Technology Sciences

Virtual Exhibition Hall

Conference attendees can continue to access the NCCN Virtual Exhibition Hall, the Reimbursement Resource Room, and Patient Advocacy Pavilion in the Digitell platform through May 20, 2021.

View Exhibition Guide


Platinum Level Sponsors

Eisai Inc.

Gold Level Sponsors

Janssen Oncology
Pharmacyclics LLC., an AbbVie Company

Silver Level Sponsor

Regeneron Pharmaceuticals

Bronze Level Sponsors

Jazz Pharmaceuticals
Sanofi Genzyme


NCCN Patient Advocacy Pavilion Sponsors




BeiGene, Ltd.
Coherus BioSciences
Eisai Inc.
Gilead-Kite Oncology
Karyopharm Therapeutics Inc.




TG Therapeutics


Virtual Reimbursement Resource Room

Corporate Council

Global Corporate Council

Save the Date!
NCCN 2022 Annual Conference
Thursday, March 31, 2022 – Saturday, April 2, 2022